Lehdistötiedote

Redeye: Initiator Pharma: Full focus on pudafensine, IP2018 is discontinued

Redeye’s analyst just published a Research Note on Initiator Pharma.

Click here to read the article

Make sure to add Initiator Pharma to your Watchlist at Redeye and our analysts will notify you if anything relevant happens regarding your companies.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se